This pilot study, sponsored by Beth Israel Deaconess Medical Center, aims to evaluate the technical feasibility of an Electrical Impedance Tomography (EIT) device for noninvasive pulmonary function testing in patients with Amyotrophic Lateral Sclerosis (ALS). The study's completion indicates a potential advancement in pulmonary monitoring technologies, particularly for ALS patients who often experience respiratory complications. The market for respiratory monitoring devices is growing, driven by increasing prevalence of chronic respiratory diseases and the need for innovative, noninvasive diagnostic tools. Competitive implications include the potential for EIT to differentiate itself from traditional pulmonary function tests (PFTs) by offering real-time imaging and assessment. Diligence considerations should focus on regulatory pathways, reimbursement strategies, and the integration of EIT into existing clinical workflows.